Cardiovascular disease determinants in chronic renal failure: Clinical approach and treatment

128Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction. Cardiovascular disease (CVD), as the leading cause of morbidity and mortality in patients on renal replacement therapy (RRT), has a central role in everyday nephrological practice. Methods. Consensus was reached on key points relating to the clinical approach and treatment of the main cardiovascular risk factors in RRT patients (hypertension, anaemia, hyperparathyroidism, dyslipidaemia, new emerging risk factors). In addition, the role of convective treatments on cardiovascular outcomes was examined. Results. Hypertension should be managed by aiming at blood pressure values of ≤ 140/90 mmHg (≤160/90 mmHg in the elderly), firstly by ensuring target dry body weight is achieved. No single class of drug has proved superior to others in RRT patients, provided that the blood pressure target is achieved, although ACE inhibitors have shown specific organ protection in high-risk patients (HOPE study) and are well tolerated. Anaemia should be managed by using erythropoietin and iron supplements, aiming at haemoglobin levels of 12 g/dl and keeping serum ferritin levels < 500 ng/ml. The management of hyperparathyroidism is currently unsatisfactory, as calcium supplements have the potential to increase cardiovascular calcification. While awaiting new calcium- and aluminium-free phosphate binders, it is essential to ensure dialysis adequacy. Clinical studies are in progress to assess the real impact of lipid-lowering drugs in RRT. In the meantime, serum LDL-cholesterol < 160 mg/dl and triglycerides < 500 mg/dl may be desirable targets. The impact of new emerging risk factors (inflammation and chronic infection, hyperhomocysteinaemia, metabolic waste-product accumulation) and their proper management are still under research. Convective dialysis treatments may confer some degree of protection from dialysis-related amyloidosis and mortality, but clinical data on this important issue are still controversial and no definitive conclusions can be drawn at present. Conclusion. CVD prevention and treatment is a great challenge for the nephrologist. Achieving evidence-based consensus can help in encouraging the implementation of best clinical practice in line with the progress of current knowledge.

References Powered by Scopus

Atherosclerosis - An inflammatory disease

20154Citations
N/AReaders
Get full text

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

8412Citations
N/AReaders
Get full text

1999 world health organization-international society of hypertension guidelines for the management of hypertension

3194Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chronic kidney disease: Effects on the cardiovascular system

1288Citations
N/AReaders
Get full text

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

668Citations
N/AReaders
Get full text

Cardiovascular and noncardiovascular mortality among patients starting dialysis

632Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Locatelli, F., Bommer, J., London, G. M., Martín-Malo, A., Wanner, C., Yaqoob, M., & Zoccali, C. (2001). Cardiovascular disease determinants in chronic renal failure: Clinical approach and treatment. Nephrology Dialysis Transplantation, 16(3), 459–468. https://doi.org/10.1093/ndt/16.3.459

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

47%

Professor / Associate Prof. 9

30%

Researcher 6

20%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 27

79%

Agricultural and Biological Sciences 5

15%

Chemistry 1

3%

Nursing and Health Professions 1

3%

Save time finding and organizing research with Mendeley

Sign up for free